Dhaval Bhanusali is a board-certified dermatologist, Clinical Instructor at Mount Sinai, and founder of Hudson Dermatology and Laser Surgery — and unusually for the field, his work extends well past the exam room into formulation, digital health, prescription access, and beauty-company development. That’s worth examining for a reason bigger than celebrity clients or product launches. Modern dermatology has genuine infrastructure problems: prescription cost, fragmented recommendations, a beauty industry hungry for medical credibility to borrow. Bhanusali keeps moving toward those systems instead of staying inside one narrow clinical lane.
The interesting question isn’t whether he’s a good dermatologist. It’s what happens when a physician becomes a builder inside the commercial systems surrounding care, not just a participant in them.
The credentials are current and specific
Mount Sinai lists Bhanusali as board-certified by the American Board of Dermatology and a Clinical Instructor in Dermatology. His training runs through Michigan State University College of Osteopathic Medicine, an internship at Stony Brook, and dermatology residency at Mount Sinai West. Hudson Dermatology describes his practice focus as scars, hair loss, laser surgery, and innovation — areas where cosmetic outcome, medical diagnosis, and device selection tend to overlap fast.
He treats access itself as a design problem
His practice biography describes professional projects that run past the exam room, and some of that work sits closer to prescription access than to treatment itself — the unglamorous business of making certain compounded dermatologic prescriptions easier and cheaper for a patient to actually obtain. The exact economics of any venture built around that will keep shifting. The underlying idea is more durable: a prescription can be clinically perfect on paper and still fail as actual care if nobody can obtain or afford it.
That’s a real consumer-health distinction, not a technicality. Efficacy on paper doesn’t solve friction at the pharmacy counter, insurance exclusions, or the plain cost of staying on a treatment long enough for it to matter. Access shouldn’t lower prescribing standards. It should force the system to actually solve the administrative and financial mess around good care instead of pretending that mess is a separate problem from the result.
Technology reduces friction and creates new conflicts in the same motion
Bhanusali’s work also runs through digital health and product development. When a physician helps build the platform, the recommendation engine, or the formula itself, medical expertise moves upstream into the actual system design — genuinely valuable, since clinicians know exactly where patients get stuck in a way a conference room full of product managers usually doesn’t.
The trade-off is conflict visibility. A founder or adviser can have real financial relationships with the systems being discussed. That doesn’t make the work unreliable. It means the audience needs clear disclosure and product-level evidence, not permission to let dermatologist involved quietly become the entire verdict.
Formulation work has to be judged at the formula, not the résumé
Beauty companies increasingly recruit dermatologists during development, which can genuinely improve ingredient selection and claims discipline. It can also produce a halo effect where the physician’s credentials get asked to prove the finished bottle actually works, which is a job credentials were never built to do.
A dermatologist’s involvement tells you something real about the development process. It doesn’t answer what the consumer still needs to know: what the formula is actually for, whether the finished product itself was tested, how meaningful the result was, and what’s already sitting in the cabinet doing the same job for less. Medical involvement is a feature. It was never a substitute for the evidence file.
Device innovation needs the exact same separation
Device-based aesthetics is particularly vulnerable to authority stacking — physician, machine, patent language, and dramatic before-and-after photography can make a treatment feel more settled than the actual evidence supports. Keep the layers apart: what exact device, for what indication, what regulatory status applies to that specific use, and how much of the outcome depends on operator skill versus the machine itself. The more futuristic the device looks, the more useful the boring questions become.
Not every friction deserves a platform
Innovation culture has a real temptation to assume every inconvenience deserves an app and every routine needs optimizing into software. Sometimes the better dermatology system is genuinely unglamorous: a clear diagnosis, a tolerable generic, a pharmacy the patient can actually use, and a follow-up plan that doesn’t require downloading anything.
The standard worth applying isn’t novelty. It’s whether the system actually reduces cost, confusion, or delay without quietly weakening the quality of the decision underneath it.
The physician-founder model needs a genuinely clean audit trail
A clinician can be a strong founder precisely because medical experience surfaces real unsolved problems. The same clinician can also profit directly when their proposed solution wins. Neither fact needs a cynical response — it needs role clarity. Is this person speaking as the treating dermatologist, the founder, or the paid adviser in this specific sentence? Which claims come from independent evidence and which come from the company itself? Good disclosure protects trust precisely because it lets the audience see the whole decision instead of asking a credential to quietly cover for a business model. Lara Devgan sits in the same position with a skincare company attached, and the questions do not change.
Sources worth opening
- Mount Sinai: current academic role, dermatology training, board certification, and affiliations
- Hudson Dermatology and Laser Surgery: current practice focus and professional projects
What Bhanusali’s career actually shows is dermatology treated as more than a sequence of appointments — cost, access, formulation, and distribution all genuinely change whether care works in real life, outside the exam room. The caution runs just as clear: whenever any physician becomes a builder, the solution owes more transparency, not less — not because a particular founder has withheld it, but because a medical credential makes it far too easy for everyone to stop asking. A better system earns trust by making its evidence and incentives easy to actually see.
Editorial note: This profile is based on public academic and practice information checked August 8, 2026. It is not medical advice, a personal endorsement, or a claim of treatment or product experience.